Back to dashboard
Medicare AdvantagePrior AuthHigh impact

Update to Medical Benefit Drug Coverage for Medical Mutual Medicare Advantage Plans - November 2020

Medical Mutual of Ohio·Rheumatology, Oncology, Hematology +2 more·Pharmacy
Effective date
Jan 1, 2021
We identified it
Jun 20, 2026
Days to comply

Summary

Effective January 1, 2021, Medical Mutual Medicare Advantage plans will require step therapy for multiple specialty medications, with several drugs moving from preferred to non-preferred status. Members new to therapy must trial preferred alternatives before non-preferred drugs can be prescribed, requiring providers to follow coverage determination processes for exceptions.

Action Required

Action needed
By January 1, 2021: Providers must implement step therapy protocols for Medical Mutual Medicare Advantage members starting new therapies with the listed medications. Update EMR templates to document trial of preferred drugs before prescribing non-preferred alternatives. Billing team must verify step therapy compliance before submitting claims and follow Medical Mutual coverage determination process when requesting exceptions for non-preferred drugs. Claims for non-preferred drugs without proper step therapy documentation or prior authorization will be denied.

Affected Billing Codes

Q5103
Q5104
J1745
J0129
J3245
Q5121
J3262
Q5117
Q5116
Q5114
J9355
Q5113
Q5112
Q5115
Q5119
J9312
J9311
J9035
Q5107
Q5118
J0178
J2778
J3396
J0179
J2305
J3302
J3304
J9356
J0640
J0642
J0641
J1303
J1300